PCP
SNDX icon

Proficio Capital Partners’s Syndax Pharmaceuticals SNDX Stock Holding History

Proficio Capital Partners’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-328
Closed -$3K – 1309
2019
Q2 		$3K Hold
328
– – ﹤0.01% 1433
2019
Q1 		$2K Buy
+328
New +$1.87K ﹤0.01% 1400

Other funds holding SNDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Proficio Capital Partners's SNDX Position: Q3 2019 in Review

Proficio Capital Partners sold out of Syndax Pharmaceuticals (SNDX) in Q3 2019, closing a stake of 328 shares — an estimated $3K sold.

Proficio Capital Partners first reported a position in SNDX in Q1 2019 and held it in 2 quarters. The position peaked at $3K in Q2 2019. 72 funds tracked by Wall St. Rank hold SNDX as of Q3 2019.

  • Proficio Capital Partners reported no remaining Syndax Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 328 Syndax Pharmaceuticals shares in Q3 2019, an estimated $3K.
  • Proficio Capital Partners first reported a position in Syndax Pharmaceuticals in Q1 2019 and held it in 2 quarters.
  • Proficio Capital Partners's Syndax Pharmaceuticals position peaked at $3K in Q2 2019.
  • 72 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.